Be a Smart Investor
Tuesday, February 21, 2017
Gainers & Losers Of The Day: EYEG, BLPH, VSAR, MNTA, AMPH...
The FDA has turned down Amphastar's request seeking approval of intranasal Naloxone, proposed for the treatment of opioid addiction or overdose.
from RTT - Biotech http://ift.tt/2kXvXHD
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment